Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
abrdn Global Equity Impact A JETAX
- NAV / 1-Day Return 14.53 / +0.21 %
- Total Assets 43.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.150%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Global Large-Stock Growth
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.98%
- Turnover 31%
USD | NAV as of Jul 02, 2024 | 1-Day Return as of Jul 02, 2024, 10:13 PM GMT+0
Morningstar’s Analysis JETAX
Will JETAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 40.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Tetra Tech Inc | 4.85 | 2.2 Mil | Industrials |
RELX PLC | 4.84 | 2.2 Mil | Industrials |
ASML Holding NV | 4.69 | 2.1 Mil | Technology |
UnitedHealth Group Inc | 4.57 | 2.1 Mil | Healthcare |
NextEra Energy Inc | 4.15 | 1.9 Mil | Utilities |
Usd Cash | 4.02 | 1.8 Mil | Cash and Equivalents |
Merck & Co Inc | 3.96 | 1.8 Mil | Healthcare |
Novo Nordisk A/S | 3.60 | 1.6 Mil | — |
AstraZeneca PLC | 3.38 | 1.5 Mil | Healthcare |
Westinghouse Air Brake Technologies Corp | 3.09 | 1.4 Mil | Industrials |